End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
181 TWD | 0.00% | -6.70% | +165.01% |
May. 14 | Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 14 | Lumosa Therapeutics Co., Ltd. Announces the Change of Chairperson | CI |
Sales 2024 * | 59M 1.82M | Sales 2025 * | 816M 25.22M | Capitalization | 29.86B 923M |
---|---|---|---|---|---|
Net income 2024 * | -444M -13.72M | Net income 2025 * | 786M 24.29M | EV / Sales 2024 * | 502 x |
Net cash position 2024 * | 259M 8M | Net cash position 2025 * | 954M 29.49M | EV / Sales 2025 * | 35.4 x |
P/E ratio 2024 * |
-67.3
x | P/E ratio 2025 * |
38
x | Employees | 47 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.33% |
1 week | -6.70% | ||
Current month | +0.56% | ||
1 month | +6.47% | ||
3 months | -3.72% | ||
6 months | +171.77% | ||
Current year | +165.01% |
Managers | Title | Age | Since |
---|---|---|---|
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
Chia Chi Yang
DFI | Director of Finance/CFO | - | 22-01-31 |
June Kuo
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wan Lai Cheng
BRD | Director/Board Member | - | 14-07-24 |
Jung Chin Lin
CEO | Chief Executive Officer | 70 | 11-09-15 |
I Hsiung Chang
BRD | Director/Board Member | - | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 181 | 0.00% | 436,460 |
24-06-03 | 181 | +0.56% | 713,526 |
24-05-31 | 180 | -4.00% | 731,488 |
24-05-30 | 187.5 | -3.35% | 411,422 |
24-05-29 | 194 | 0.00% | 615,485 |
End-of-day quote Taipei Exchange, June 03, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.01% | 923M | |
+16.73% | 123B | |
+13.04% | 107B | |
-5.80% | 24.01B | |
+3.11% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-14.00% | 16.23B | |
+1.18% | 13.43B | |
+24.18% | 11.32B |
- Stock Market
- Equities
- 6535 Stock